Neurology Central

AAIC 2018: Could intensive blood pressure control reduce the risk of MCI and dementia?

At the Alzheimer’s Association International Conference (AAIC; 22–26 July, IL, USA), Jeff Williamson (Wake Forest School of Medicine, NC, USA) announced results from the SPRINT MIND study. For the first time, the trial demonstrated significant reductions in the risk of mild cognitive impairment (MCI) and the combination of MCI and dementia through aggressive lowering of systolic blood pressure.

The results of this large-scale, long-term clinical trial provide the strongest evidence to date about reducing risk of MCI and dementia through the treatment of high blood pressure.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.